US 5012035A
· Sartori et al.
· 1991
[cited by applicant]
US 5173851A
· Off et al.
· 1992
[cited by applicant]
US 5595342A
· McNair et al.
· 1997
[cited by applicant]
US 5628530A
· Thornton
· 1997
[cited by applicant]
US 5726092A
· Mathews et al.
· 1998
[cited by applicant]
US 5757898A
· Nishikawa
· 1998
[cited by applicant]
US 5769228A
· Wroblewski
· 1998
[cited by applicant]
US 6012035A
· Freeman et al.
· 2000
[cited by applicant]
US 6111218A
· Akers et al.
· 2000
[cited by applicant]
US 6463462B1
· Smith et al.
· 2002
[cited by applicant]
US 6595342B1
· Maritzen et al.
· 2003
[cited by applicant]
US 6726092B2
· Goldberg et al.
· 2004
[cited by applicant]
US 6757898B1
· Ilsen et al.
· 2004
[cited by applicant]
US 6769228B1
· Mahar
· 2004
[cited by applicant]
US 7155397B2
· Alexander et al.
· 2006
[cited by applicant]
US 7192741B2
· Otte et al.
· 2007
[cited by applicant]
US 7337129B1
· Lowry et al.
· 2008
[cited by applicant]
US 7346768B2
· DiRienzo
· 2008
[cited by applicant]
US 7409632B1
· DiRienzo
· 2008
[cited by applicant]
US 7426476B2
· Munoz et al.
· 2008
[cited by applicant]
US 7734483B1
· Smith et al.
· 2010
[cited by applicant]
US 7783383B2
· Eliuk et al.
· 2010
[cited by applicant]
US 7840424B2
· Wiley et al.
· 2010
[cited by applicant]
US 7856364B1
· Wiley et al.
· 2010
[cited by applicant]
US 7912741B1
· Pinsonneault
· 2011
[cited by applicant]
US 7921021B1
· Newman
· 2011
[cited by applicant]
US 8036913B1
· Pinsonneault et al.
· 2011
[cited by applicant]
US 8036914B1
· Pinsonneault
· 2011
[cited by applicant]
US 8036918B1
· Pinsonneault
· 2011
[cited by applicant]
US 8050943B1
· Wiley et al.
· 2011
[cited by applicant]
US 8060379B1
· Pinsonneault et al.
· 2011
[cited by applicant]
US 8126743B1
· Wilk
· 2012
[cited by applicant]
US 8326773B1
· Bellamy
· 2012
[cited by applicant]
US 8346571B2
· Kalies, Jr.
· 2013
[cited by examiner]
US 8412537B1
· Fenton et al.
· 2013
[cited by applicant]
US 8442847B1
· Shrivastava
· 2013
[cited by applicant]
US 8489415B1
· Ringold
· 2013
[cited by applicant]
US 8521557B1
· Ringold et al.
· 2013
[cited by applicant]
US 8560340B1
· Ringold
· 2013
[cited by applicant]
US 8639523B1
· Pinsonneault
· 2014
[cited by applicant]
US 8645162B2
· Boerger et al.
· 2014
[cited by applicant]
US 8671018B2
· Thomas et al.
· 2014
[cited by applicant]
US 8712797B1
· Bezdek et al.
· 2014
[cited by applicant]
US 8738399B1
· Abou Nader et al.
· 2014
[cited by applicant]
US 8786650B1
· Eller et al.
· 2014
[cited by applicant]
US 8799018B1
· Rea et al.
· 2014
[cited by applicant]
US 8984059B2
· Johnson
· 2015
[cited by applicant]
US 9026507B2
· Shraim et al.
· 2015
[cited by applicant]
US 9100793B2
· Johnson
· 2015
[cited by applicant]
US 9171322B2
· Spievak et al.
· 2015
[cited by applicant]
US 9356947B2
· Shraim et al.
· 2016
[cited by applicant]
US 9760871B1
· Pourfallah et al.
· 2017
[cited by applicant]
US 9779129B1
· Lequeux
· 2017
[cited by applicant]
US 9786023B2
· Cohan et al.
· 2017
[cited by applicant]
US 11443835B1
· Gangaikondan-Iyer et al.
· 2022
[cited by applicant]
US 20010039589A1
· Aho et al.
· 2001
[cited by applicant]
US 20010056359A1
· Abreu
· 2001
[cited by applicant]
US 20020002495A1
· Ullman
· 2002
[cited by applicant]
US 20020004812A1
· Motoyama
· 2002
[cited by applicant]
US 20020032582A1
· Feeney et al.
· 2002
[cited by applicant]
US 20020035484A1
· McCormick
· 2002
[cited by applicant]
US 20020087583A1
· Morgan et al.
· 2002
[cited by applicant]
US 20020111832A1
· Judge
· 2002
[cited by applicant]
US 20020143579A1
· Docherty et al.
· 2002
[cited by applicant]
US 20020147614A1
· Doerr et al.
· 2002
[cited by applicant]
US 20020188552A1
· Kavounas et al.
· 2002
[cited by applicant]
US 20030009367A1
· Morrison
· 2003
[cited by applicant]
US 20030050799A1
· Jay et al.
· 2003
[cited by applicant]
US 20030069760A1
· Gelber
· 2003
[cited by applicant]
US 20030074234A1
· Stasny
· 2003
[cited by applicant]
US 20030130875A1
· Hawash et al.
· 2003
[cited by applicant]
US 20030149625A1
· Leonardi et al.
· 2003
[cited by applicant]
US 20030229540A1
· Algiene
· 2003
[cited by applicant]
US 20040006490A1
· Gingrich et al.
· 2004
[cited by applicant]
US 20040039599A1
· Fralic
· 2004
[cited by applicant]
US 20040073456A1
· Gottlieb et al.
· 2004
[cited by applicant]
US 20040078222A1
· Khan et al.
· 2004
[cited by applicant]
US 20040078234A1
· Tallal, Jr.
· 2004
[cited by applicant]
US 20040103062A1
· Wood et al.
· 2004
[cited by applicant]
US 20040199545A1
· Wagner et al.
· 2004
[cited by applicant]
US 20040249745A1
· Baaren
· 2004
[cited by applicant]
US 20050015280A1
· Gabel et al.
· 2005
[cited by applicant]
US 20050075932A1
· Mankoff
· 2005
[cited by applicant]
US 20050080692A1
· Padam et al.
· 2005
[cited by applicant]
US 20050102169A1
· Wilson
· 2005
[cited by applicant]
US 20050154627A1
· Zuzek et al.
· 2005
[cited by applicant]
US 20050187793A1
· Myles
· 2005
[cited by applicant]
US 20050197862A1
· Paterson et al.
· 2005
[cited by applicant]
US 20050240442A1
· Lapsker et al.
· 2005
[cited by applicant]
US 20050240473A1
· Ayers, Jr. et al.
· 2005
[cited by applicant]
US 20050261939A1
· Augspurger et al.
· 2005
[cited by applicant]
US 20060020514A1
· Yered
· 2006
[cited by applicant]
US 20060026041A1
· Ullman
· 2006
[cited by applicant]
US 20060036470A1
· Oaks
· 2006
[cited by applicant]
US 20060085231A1
· Brofman
· 2006
[cited by applicant]
US 20060149595A1
· Williams et al.
· 2006
[cited by applicant]
US 20060149784A1
· Tholl et al.
· 2006
[cited by applicant]
US 20060184391A1
· Barre et al.
· 2006
[cited by applicant]
US 20060212345A1
· Soza et al.
· 2006
[cited by applicant]
US 20060224414A1
· Astrup et al.
· 2006
[cited by applicant]
US 20060224417A1
· Werner
· 2006
[cited by applicant]
US 20060224443A1
· Soza et al.
· 2006
[cited by applicant]
US 20060235747A1
· Hammond et al.
· 2006
[cited by applicant]
US 20060259363A1
· Jhetam et al.
· 2006
[cited by applicant]
US 20070005402A1
· Kennedy et al.
· 2007
[cited by applicant]
US 20070033137A1
· Provost et al.
· 2007
[cited by applicant]
US 20070043589A1
· Warren et al.
· 2007
[cited by applicant]
US 20070043595A1
· Pederson
· 2007
[cited by applicant]
US 20070050209A1
· Yered
· 2007
[cited by applicant]
US 20070050210A1
· Wiley, II
· 2007
[cited by applicant]
US 20070067186A1
· Brenner et al.
· 2007
[cited by applicant]
US 20070094133A1
· Anandarao et al.
· 2007
[cited by applicant]
US 20070136100A1
· Daugherty et al.
· 2007
[cited by applicant]
US 20070162303A1
· Wiley et al.
· 2007
[cited by applicant]
US 20070185799A1
· Harrison et al.
· 2007
[cited by applicant]
US 20070191985A1
· Bain
· 2007
[cited by applicant]
US 20070202886A1
· Dhebri et al.
· 2007
[cited by applicant]
US 20070204043A1
· Espinosa et al.
· 2007
[cited by applicant]
US 20070219813A1
· Moore
· 2007
[cited by applicant]
US 20070233525A1
· Boyle
· 2007
[cited by applicant]
US 20070250341A1
· Howe et al.
· 2007
[cited by applicant]
US 20070260750A1
· Feied et al.
· 2007
[cited by applicant]
US 20070299915A1
· Shraim et al.
· 2007
[cited by applicant]
US 20080033750A1
· Swiss et al.
· 2008
[cited by applicant]
US 20080103836A1
· Park et al.
· 2008
[cited by applicant]
US 20080183492A1
· Warren et al.
· 2008
[cited by applicant]
US 20080215361A1
· Nunnari et al.
· 2008
[cited by applicant]
US 20090006141A1
· Karr
· 2009
[cited by applicant]
US 20090083064A1
· Mahinda
· 2009
[cited by applicant]
US 20090100099A1
· Buckwalter
· 2009
[cited by applicant]
US 20090106313A1
· Boldyga
· 2009
[cited by applicant]
US 20090112707A1
· Weiss et al.
· 2009
[cited by applicant]
US 20090204477A1
· Urso
· 2009
[cited by applicant]
US 20090287558A1
· Seth et al.
· 2009
[cited by applicant]
US 20090313112A1
· Champ et al.
· 2009
[cited by applicant]
US 20090327363A1
· Cullen et al.
· 2009
[cited by applicant]
US 20100161353A1
· Mayaud
· 2010
[cited by applicant]
US 20100217622A1
· Brown et al.
· 2010
[cited by applicant]
US 20100287001A1
· Pearce et al.
· 2010
[cited by applicant]
US 20110015978A1
· Welch, Jr.
· 2011
[cited by applicant]
US 20110112871A1
· Simonowski et al.
· 2011
[cited by applicant]
US 20110161109A1
· Pinsonneault et al.
· 2011
[cited by applicant]
US 20110196697A1
· Akers
· 2011
[cited by applicant]
US 20120053958A1
· Marshall et al.
· 2012
[cited by applicant]
US 20120136809A1
· Cannata et al.
· 2012
[cited by applicant]
US 20120166268A1
· Griffiths
· 2012
[cited by applicant]
US 20120179481A1
· Patel et al.
· 2012
[cited by applicant]
US 20120185263A1
· Emert
· 2012
[cited by applicant]
US 20120185264A1
· Demogenes et al.
· 2012
[cited by applicant]
US 20120253829A1
· John et al.
· 2012
[cited by applicant]
US 20120253830A1
· John
· 2012
[cited by examiner]
US 20120253831A1
· John et al.
· 2012
[cited by applicant]
US 20120253832A1
· John et al.
· 2012
[cited by applicant]
US 20120253833A1
· John et al.
· 2012
[cited by applicant]
US 20120253846A1
· John et al.
· 2012
[cited by applicant]
US 20130046610A1
· Abraham
· 2013
[cited by applicant]
US 20130144715A1
· Kranzley et al.
· 2013
[cited by applicant]
US 20130179180A1
· Patra
· 2013
[cited by applicant]
US 20130191147A1
· Harrell
· 2013
[cited by examiner]
US 20130246082A1
· Brylawski et al.
· 2013
[cited by applicant]
US 20140039911A1
· Iyer
· 2014
[cited by applicant]
US 20140088985A1
· Grant et al.
· 2014
[cited by applicant]
US 20140214435A1
· Previdi
· 2014
[cited by applicant]
US 20140249861A1
· Gamble et al.
· 2014
[cited by applicant]
US 20140278456A1
· Milosevich et al.
· 2014
[cited by applicant]
US 20140278531A1
· Gupta
· 2014
[cited by applicant]
US 20150032465A1
· Sundar et al.
· 2015
[cited by applicant]
US 20150088557A1
· Huynh et al.
· 2015
[cited by applicant]
US 20150142479A1
· Porter et al.
· 2015
[cited by applicant]
US 20150154565A1
· Kaehler et al.
· 2015
[cited by applicant]
US 20150154588A1
· Purves et al.
· 2015
[cited by applicant]
US 20150269695A1
· Pinsonneault et al.
· 2015
[cited by applicant]
US 20150278472A1
· King
· 2015
[cited by applicant]
US 20150332422A1
· Gilmartin
· 2015
[cited by applicant]
US 20160012465A1
· Sharp
· 2016
[cited by applicant]
US 20160103978A1
· Stong
· 2016
[cited by applicant]
US 20160267544A1
· Flood et al.
· 2016
[cited by applicant]
US 20160267545A1
· Glass et al.
· 2016
[cited by applicant]
US 20160307195A1
· Cantwell et al.
· 2016
[cited by applicant]
US 20160321406A1
· Timmerman et al.
· 2016
[cited by applicant]
US 20160321410A1
· Timmerman et al.
· 2016
[cited by applicant]
US 20160358142A1
· Hillen
· 2016
[cited by applicant]
US 20160358293A1
· Berger et al.
· 2016
[cited by applicant]
US 20170039331A1
· Bezdek
· 2017
[cited by examiner]
US 20170220768A1
· Tanner, Jr. et al.
· 2017
[cited by applicant]
US 20170323295A1
· Kranzley et al.
· 2017
[cited by applicant]
US 20170324695A1
· Fischer et al.
· 2017
[cited by applicant]
US 20170329922A1
· Eberting et al.
· 2017
[cited by applicant]
US 20180012244A1
· Leonardi
· 2018
[cited by applicant]
US 20180075212A1
· Kubey
· 2018
[cited by examiner]
US 20180366810A1
· Nero et al.
· 2018
[cited by applicant]
US 20200105392A1
· Karkazis et al.
· 2020
[cited by applicant]
US 20200372988A1
· Bezdek et al.
· 2020
[cited by applicant]
US 20210319887A1
· Derrick, Jr. et al.
· 2021
[cited by applicant]
US 20210374872A1
· Stewart et al.
· 2021
[cited by applicant]
AU 2003243327A
· 2003
[cited by applicant]
CA 2482370A1
· 2006
[cited by applicant]
CA 2792252A1
· 2013
[cited by applicant]
CA 2810686A1
· 2013
[cited by applicant]
CN 102362778
· 2012
[cited by applicant]
KR 100755440
· 2007
[cited by applicant]
KR 100793852
· 2008
[cited by applicant]
KR 101038074
· 2011
[cited by applicant]
KR 101101692
· 2011
[cited by applicant]
KR 20110138108
· 2011
[cited by applicant]
KR 20110138572
· 2011
[cited by applicant]
KR 101154858
· 2012
[cited by applicant]
WO WO1991006917A1
· 1991
[cited by applicant]
WO WO1995003569A2
· 1995
[cited by applicant]
WO WO1997025682A1
· 1997
[cited by applicant]
WO WO1998050871A1
· 1998
[cited by applicant]
WO WO2000039737A1
· 2000
[cited by applicant]
WO WO2003098401A2
· 2003
[cited by applicant]
WO WO2007025295A2
· 2007
[cited by applicant]
WO WO2007094772A1
· 2007
[cited by applicant]
WO WO2008092109A2
· 2008
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 16/816,460, dated Aug. 10, 2023, 14 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/144,426, dated Jul. 13, 2023, 17 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/158,118, dated Jul. 13, 2023, 18 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/705,919, dated Aug. 17, 2023, 68 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/162,461, dated Aug. 24, 2023, 2 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 16/816,460, dated Aug. 1, 2024, 3 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/162,461, dated Aug. 19, 2024, 2 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 18/098,150, dated Aug. 27, 2024, 61 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Interview Summary received for U.S. Appl. No. 17/675,616, dated Aug. 15, 2024,8 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/846,373, dated Apr. 5, 2024, 76 pages.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/674,366, dated Jun. 5, 2024, 54 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/162,461, dated Jun. 4, 2024, 38 pages, US.
[cited by applicant]
Liu, Shiyong, et al., “Evaluating Cost-Effectiveness of Treatment Options for Diabetes Patients Using System Dynamics Modeling”, Proceeding of the 2018 Winter Simulation Conference (WSC), Dec. 9-12, 2018, pp. 2577-2588,…
[cited by applicant]
Tiriveedhi, V., “Impact of Precision Medicine on Drug Repositioning and Pricing: A Too Small to Thrive Crisis”, Journal of Personalized Medicine, Nov. 5, 2018, 11 pages, vol. 8, No. 36, MDPI, Switzerland.
[cited by applicant]
United States Patent and Trademark Office, Notice of Allowance received for U.S. Appl. No. 17/705,919, dated Sep. 3, 2024, 13 pages, USA.
[cited by applicant]
United States Patent and Trademark Office, Notice of Allowance received for U.S. Appl. No. 17/675,616, dated Sep. 25, 2024, 21 pages, USA.
[cited by applicant]
United States Patent and Trademark Office, Notice of Allowance received for U.S. Appl. No. 17/676,437, dated Sep. 25, 2024, 20 pages, USA.
[cited by applicant]
United States Patent and Trademark Office, Examiner Interview Summary received for U.S. Appl. No. 18/098,150, dated Nov. 18, 2024, 3 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 16/816,460, dated Nov. 21, 2024, 28 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Examiner Interview Summary received for U.S. Appl. No. 17/175,939, dated Dec. 3, 2024, 2 pages, US.
[cited by applicant]
Coase, R. H., “The Nature of the Firm”, Economica, Nov. 1937, pp. 386-405, vol. 4, No. 16, Blackwell Publishing for London School of Economics and Political Science, retrieved from the Internet at http://www.jstor.org/s…
[cited by applicant]
Gemmill, Marin, “The price elasticity of demand for prescription drugs: An exploration of demand in different settings”, Doctor of Philosophy Thesis submitted to the London School of Economics and Political Science, Jan…
[cited by applicant]
United States Patent and Trademark Office, Advisory Action and Examiner-Initiated Interview Summary received for U.S. Appl. No. 17/705,919, dated Jun. 25, 2024, 33 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Examiner's Answer received for U.S. Appl. No. 16/867,286, dated Jun. 28, 2024, 9 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/144,426, dated Jul. 18, 2024, 19 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/158,118, dated Jul. 18, 2024, 22 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Notice of Allowance received for U.S. Appl. No. 17/846,373, dated Jul. 25, 2024, 16 pages, US.
[cited by applicant]
Bowman, Michelle, et al., “Risk Assessment of Pharmacies & Electronic Prescriptions,” 2019 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining (ASONAM), Aug. 27-30, 2019, pp. 641-644, Va…
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 16/816,460, dated May 3, 2024, 22 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/675,616, dated May 8, 2024, 74 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/676,437, dated May 9, 2024, 73 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 16/867,286, dated Sep. 19, 2023, 16 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 16/816,460, dated Oct. 19, 2023, 3 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/162,461, dated Oct. 19, 2023, 25 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/144,426, dated Mar. 21, 2024, 5 pages.
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/674,366, dated Mar. 22, 2024, 6 pages.
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/705,919, dated Feb. 28, 2024, 61 pages.
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/175,939, dated Mar. 1, 2024, 24 pages.
[cited by applicant]
United States Patent and Trademark Office, Examiner Interview Summary received for U.S. Appl. No. 17/144,426, dated Oct. 22, 2024,8 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Examiner Interview Summary received for U.S. Appl. No. 17/158,118, dated Oct. 22, 2024,8 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/501,532, dated Oct. 17, 2024, 37 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/499,976, dated Oct. 1, 2024, 79 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/175,939, dated Oct. 24, 2024, 17 pages, U.S.
[cited by applicant]
U.S. Appl. No. 16/816,460, “Adaptive System and Method for Adjudicating Claims to Reduce Member Responsibility”, Unpublished (Filing Date Mar. 12, 2020), (Michael Rea, Inventor), (RC Savings, LLC, Assignee).
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 16/816,460, dated Mar. 3, 2023, 14 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/162,461, dated May 19, 2023, 23 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/158,118, dated May 26, 2023, 5 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/674,366, dated Jun. 6, 2023, 75 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Miscellaneous Office Action, Restarting Period, received for U.S. Appl. No. 17/175,939, dated Jun. 14, 2023, 23 pages, U.S.
[cited by applicant]
Viswanthan, Meera, et al., “Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United States,” Annals of Internal Medicine, Dec. 4, 2012, retrieved from the Internet at <http…
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/144,426, dated Dec. 19, 2024, 22 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/158,118, dated Dec. 19, 2024, 24 pages, US.
[cited by applicant]
“Pharmacy Reject Codes” NCPDP, 5 pages.
[cited by applicant]
“St. Vincent's first to use Birmingham startup's information system.” The Birmingham News [Online] Apr. 11, 2005. URL: http://www.awarix.com.
[cited by applicant]
“St. Vincent's is Digital Flagship” D. Lockridge; Birmingham Medical News [Online] Sep. 2005.
[cited by applicant]
“Two automatic identification technology, neither new in the sense if being recent developments . . . ” Patient Safety & Quality Healthcare [Online] Aug. 2005_ URL: http://www_awarix.com.
[cited by applicant]
Advisory Action for U.S. Appl. No. 14/193,294 mailed Nov. 9, 2017, 3 pages.
[cited by applicant]
Advisory Action for U.S. Appl. No. 15/085,166 dated Apr. 11, 2019, 4 pages.
[cited by applicant]
Advisory Action for U.S. Appl. No. 15/085,166 dated Apr. 29, 2020, 3 pages.
[cited by applicant]
Advisory Action for U.S. Appl. No. 15/137,371 mailed Feb. 25, 2019, 5 pages.
[cited by applicant]
Advisory Action for U.S. Appl. No. 15/427,746 mailed Jul. 2, 2019, 2 pages.
[cited by applicant]
Advisory Action received for U.S. Appl. No. 15/085,166, dated Jan. 29, 2021, 3 pages, US.
[cited by applicant]
Almaro, Moshe; “Recovery and Reuse of Unused Prescription Drugs” MIT What Matters: Aug. 2005.
[cited by applicant]
American Hospital Association, “Drug Price Proposals”, dated Apr. 2019, retrieved from the Internet at <URL: https://www.aha.org/system/files/media/file/2019/04/aha-drug-policy-recommendations_2.pdf>, 8 pages.
[cited by applicant]
American Society of Health-System Pharmacists (ASHP), “Is Prescribing the Next Step in the Evolution of Pharmacy?” May 15, 2012.
[cited by applicant]
Anonymous, ACS to Demonstrate Electronic Health Record Solution Suite at MMIS 2007 Conference; EHR Tools Consolidate Data, Provide Useful Information at the Point of Care for Medicaid Providers, Payers, and Patients, PR…
[cited by applicant]
Anonymous, Medic; On-line Goes In-House, Chain Store Age Executive, Jan. 1987, vol. 63, Issue 1, USA; Abstract only.
[cited by applicant]
Anonymous, Pharmacy Industry Leaders Launch Firm to Supply Real-Time Data, PR Newswire, Jul. 30, 2001, p. 1, New York, NY, USA.
[cited by applicant]
Anonymous, TechRx Announces Successful Beta Deployment of T-Rex. PR Newswire. May 13, 2002.
[cited by applicant]
California Health Care Foundation, “When the Price Is Not Right: State Options on Prescription Drug Pricing”, dated Jun. 2016, retrieved from the Internet at: <URL: https://www.chcf.org/wp-content/uploads/2017/12/PDF-Wh…
[cited by applicant]
Cepeda, Maria Soledad, et al., “Quantification of missing prescriptions in commercial claims databases : results of a cohort study.”, Pharmacoepidemiology and Drug Safety, Apr. 2017, pp. 386-392, vol. 26, Epub Jan. 25, …
[cited by applicant]
Chu, Kuan-Yu, et al., “Incremental analysis of the reengineering of an outpatient billing process: an empirical study in a public hospital”, BMC Health Services Research, Jun. 13, 2013, vol. 13, No. 215, 8 pages, BioMed…
[cited by applicant]
CMS Updates Drug Dashboards with Prescription Drug Pricing and Spending Data, Data, Medicare Part D, Prescription drugs (Mar. 14, 2019).
[cited by applicant]
Consalvo, Bob; “City of Boston in the City Council” hearing notice, Dec. 6, 2006.
[cited by applicant]
Coping with Information Overload. The News Source for Healthcare Information Technology [Online] Nov. 2004. URL: http://www.awarix.com.
[cited by applicant]
Decision to Grant European Patent Application No. 13809457.8 dated May 18, 2017.
[cited by applicant]
Dubois, Robert W., “Rx Drug Costs: List Prices Versus Net Prices and the Importance of Staying Within the Data”, Health Affairs Blog, Mar. 2019, 7 pages.
[cited by applicant]
Examiner's Answer for U.S. Appl. No. 14/145,027 mailed Sep. 7, 2016, 27 pages.
[cited by applicant]
Extended European Search Report for European Application No. 13809457.8 dated Apr. 15, 2016, 6 pages.
[cited by applicant]